A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the ...

Medications and therapy are two of the most common treatments for anxiety, and they're highly effective. But there are also natural anxiety remedies like exercise, meditation and breathing ...

A team of researchers at Kobe Gakuin University in Japan have genetically engineered insulin-fused proteins capable of ...

Dementia is not a natural part of ageing, although the risk increases with age ... If I know what cannot be unknown, what then? Treatments are coming, but they’re not here yet. The paradox is that ...

Therefore, a doctor may diagnose and treat individuals with pseudodementia as though they have dementia. Ask the tough question: “Are you considering suicide?” Listen to the person without ...

“This would be, if it was successful, the first treatment available for this condition.” Prof Terence said dementia was linked to a build-up of “abnormal” proteins, and their drug was able ...

Dementia usually affects the elderly, and the symptoms of the disease can be considered a natural change that often comes with aging. Memory loss. One of the most common symptoms of Alzheimer's ...

Shared genetic pathways and overlapping processes in the brain may help explain the connection between ALS and dementia ... be variants of ALS and not the natural result of progressive ...

Our mission is to deliver unbiased, fact-based reporting that holds power to account and exposes the truth. Whether $5 or $50, every contribution counts. Support us to deliver journalism without ...

Dementia can lead to challenges with communication ... ways to communicate your thoughts or questions. Frustration is a natural part of the process, but making an effort to keep your tone friendly ...

While hormone therapy can help some women in perimenopause or menopause, there are also natural remedies for vaginal dryness that can provide relief. “Vaginal dryness, especially in middle age ...

Cognition is advancing CT1812 in the Phase 2 ‘SHIMMER’ clinical trial for the treatment of dementia with Lewy bodies with data readout in the fourth quarter of 2024 PURCHASE, N.Y., Oct. 01, 2024 ...